MedElevator Войти в исследования
← Поиск публикаций

DOI 10.1016/j.ejphar.2024.176488

Медицинская библиотека · European journal of pharmacology · 2024

Overexpressing of the GIPC1 protects against pathological cardiac remodelling.

Sun Xi, Han Yanna, Yu Yahan, Chen Yujie, Dong Chaorun, Lv Yuan, Qu Huan, Fan Zheyu, Yu Yi, Sang Yaru, Tang Wenxia, Liu Yu, Ju Jiaming, Zhao Dan, Bai Yunlong

СтатьяПеревод пока не подготовлен

Аннотация

OBJECTIVE

Pathological cardiac remodelling, including cardiac hypertrophy and fibrosis, is a key pathological process in the development of heart failure. However, effective therapeutic approaches are limited. The β-adrenergic receptors are pivotal signalling molecules in regulating cardiac function. G-alpha interacting protein (GAIP)-interacting protein, C-terminus 1 (GIPC1) is a multifunctional scaffold protein that directly binds to the C-terminus of β1-adrenergic receptor (β1-adrenergic receptor). However, little is known about its roles in heart function. Therefore, we investigated the role of GIPC1 in cardiac remodelling and its underlying molecular mechanisms.

METHODS

Pathological cardiac remodelling in mice was established via intraperitoneal injection of isoprenaline for 14 d or transverse aortic constriction surgery for 8 weeks. Myh6-driving cardiomyocyte-specific GIPC1 conditional knockout (GIPC1 cKO) mice and adeno-associated virus 9 (AAV9)-mediated GIPC1 overexpression mice were used. The effect of GIPC1 on cardiac remodelling was assessed using echocardiographic, histological, and biochemical analyses.

RESULTS

GIPC1 expression was consistently reduced in the cardiac remodelling model. GIPC1 cKO mice exhibited spontaneous abnormalities, including cardiac hypertrophy, fibrosis, and systolic dysfunction. In contrast, AAV9-mediated GIPC1 overexpression in the heart attenuated isoproterenol-induced pathological cardiac remodelling in mice. Mechanistically, GIPC1 interacted with the β1-adrenergic receptor and stabilised its expression by preventing its ubiquitination and degradation, maintaining the balance of β1-adrenergic receptor/β2-adrenergic receptor, and inhibiting hyperactivation of the mitogen-activated protein kinase signalling pathway.

CONCLUSIONS

These results suggested that GIPC1 plays a cardioprotective role and is a promising therapeutic target for the treatment of cardiac remodelling and heart failure.

Для цитирования: Sun Xi, Han Yanna, Yu Yahan, Chen Yujie, Dong Chaorun, Lv Yuan, Qu Huan, Fan Zheyu, Yu Yi, Sang Yaru, Tang Wenxia, Liu Yu, Ju Jiaming, Zhao Dan, Bai Yunlong. Overexpressing of the GIPC1 protects against pathological cardiac remodelling.. European journal of pharmacology. 2024. DOI: 10.1016/j.ejphar.2024.176488.

Предметные рубрики MeSH

Подготовка и перевод публикации
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…

История · было → стало

Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.

Тип публикации указан по данным источника. Уровень доказательности автоматически не присваивается.